125 related articles for article (PubMed ID: 2835707)
21. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
22. Class II antigen expression on human cultured Schwann cells from patients with Charcot-Marie-Tooth disease.
De Martini I; Bianchini D; Schenone A; Cadoni A; Zicca A; Zaccheo D; Mancardi GL
Neurosci Lett; 1989 May; 100(1-3):331-4. PubMed ID: 2761783
[TBL] [Abstract][Full Text] [Related]
23. Possible T4-HLA class II interaction as an essential event in antigen-specific helper T lymphocyte-dependent B cell activation.
Fischer A; Sterkers G; Charron D; Durandy A
Eur J Immunol; 1986 Sep; 16(9):1111-6. PubMed ID: 2944748
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporine does not abrogate donor-specific class II expression in allografted human heart.
Rose M; Navarette C; Yacoub M; Festenstein H
Transplant Proc; 1988 Jun; 20(3 Suppl 3):333-40. PubMed ID: 3291265
[No Abstract] [Full Text] [Related]
25. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
Brooks CF; Moore M
Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
[TBL] [Abstract][Full Text] [Related]
26. Association of HLA-DR/DQ polymorphism with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in Tunisian patients.
Mrad M; Fekih-Mrissa N; Mansour M; Seyah A; Riahi A; Gritli N; Mrissa R
Transfus Apher Sci; 2013 Dec; 49(3):623-6. PubMed ID: 23968987
[TBL] [Abstract][Full Text] [Related]
27. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
28. [Application of the avidin-biotin-peroxidase complex (ABC) method with a monoclonal antibody to the HLA-DR antigen in immunoelectron microscopy].
Chen BF; Lian P
Zhonghua Bing Li Xue Za Zhi; 1986 Jun; 15(2):87-9. PubMed ID: 2946451
[No Abstract] [Full Text] [Related]
29. The conceptual introduction of the "demyelinating Schwann cell" in peripheral demyelinating neuropathies.
Park HT; Kim JK; Tricaud N
Glia; 2019 Apr; 67(4):571-581. PubMed ID: 30378179
[TBL] [Abstract][Full Text] [Related]
30. Schwann cell-derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment.
Allard DE; Wang Y; Li JJ; Conley B; Xu EW; Sailer D; Kimpston C; Notini R; Smith CJ; Koseoglu E; Starmer J; Zeng XL; Howard JF; Hoke A; Scherer SS; Su MA
J Clin Invest; 2018 Oct; 128(10):4727-4741. PubMed ID: 30222134
[TBL] [Abstract][Full Text] [Related]
31. Examination of two anti-HLA-DR-like monoclonal antibodies.
Nikolova EB
Haematologia (Budap); 1986; 19(2):133-40. PubMed ID: 2428703
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic and proliferative properties of Schwann cells from nerves of diabetic patients.
Scarpini E; Doronzo R; Baron P; Moggio M; Basellini A; Scarlato G
Int J Clin Pharmacol Res; 1992; 12(5-6):211-5. PubMed ID: 1301402
[TBL] [Abstract][Full Text] [Related]
33. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
34. Xenogeneic recognition of soluble and cell surface HLA class II antigens by proliferative murine T cells.
Viguier M; Lotteau V; Charron D; Debré P
Eur J Immunol; 1987 Nov; 17(11):1540-6. PubMed ID: 2960540
[TBL] [Abstract][Full Text] [Related]
35. Axonal neuropathy associated with interferon-alpha treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells.
Quattrini A; Comi G; Nemni R; Martinelli V; Villa A; Caimi M; Wrabetz L; Canal N
Acta Neuropathol; 1997 Nov; 94(5):504-8. PubMed ID: 9386785
[TBL] [Abstract][Full Text] [Related]
36. HLA-D/DR identity results in a positive CML reaction.
Buc M; Porubská S; Bencová M; Nyulassy S; Stefanovic J
Folia Biol (Praha); 1989; 35(2):78-89. PubMed ID: 2659391
[TBL] [Abstract][Full Text] [Related]
37. Induction of HLA-DR antigen expression in human endometrial epithelial cells in vitro by recombinant gamma-interferon.
Tabibzadeh SS; Gerber MA; Satyaswaroop PG
Am J Pathol; 1986 Oct; 125(1):90-6. PubMed ID: 2430458
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
[TBL] [Abstract][Full Text] [Related]
39. The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis.
Campbell DA; du Bois RM; Butcher RG; Poulter LW
Clin Exp Immunol; 1986 Jul; 65(1):165-71. PubMed ID: 3791697
[TBL] [Abstract][Full Text] [Related]
40. Epithelial HLA-DR expression and lymphocyte subsets in gastric mucosa in type B chronic gastritis.
Papadimitriou CS; Ioachim-Velogianni EE; Tsianos EB; Moutsopoulos HM
Virchows Arch A Pathol Anat Histopathol; 1988; 413(3):197-204. PubMed ID: 3135657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
